Concepedia

Author

Kathy Paschetto

AstraZeneca (United States)

Also Known As

K. A. Paschetto, K. Paschetto, Katherine A. Paschetto, Kathy A. Paschetto, Kathy Paschetto

10

Publications

418

Citations

7

H-Index

20

Concepts

All Affiliations

AstraZeneca (United States)Wilmington University
KP

About

Kathy Paschetto is an author at AstraZeneca (United States) specializing in biochemistry, medicine, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Biochemistry

6

6

403

2

Medicine

5

5

390

3

Natural Sciences

2

2

38

4

Cell Biology

1

1

254

5

Cellular Physiology

1

1

254

Kathy Paschetto

×

6

Publications

403

Citations

6

H-Index

YearCitations

ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide

Katalin Kálmán, Michael W. Pennington, Mark D. Lanigan,

Journal of Biological Chemistry

1998

254

MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit

Robert A. Volkmann, Christopher M. Fanger, David Anderson,

PLoS ONE

2016

63

Neomycin Is an Agonist at a Polyamine Site on the N‐Methyl‐D‐Aspartate Receptor

Linda M. Pullan, Robert J. Stumpo, Richard J. Powel,

Journal of Neurochemistry

1992

35

PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits

Feng Yi, Nirvan Rouzbeh, Kasper B. Hansen,

Neuropharmacology

2020

23

Mechanism of Inhibition of Fatty Acid Amide Hydrolase by Sulfonamide-Containing Benzothiazoles: Long Residence Time Derived from Increased Kinetic Barrier and Not Exclusively from Thermodynamic Potency

Gaochao Tian, Kathy Paschetto, Farzin Gharahdaghi,

Biochemistry

2011

15

Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase

Clay W. Scott, Gaochao Tian, Xiao Yu,

European Journal of Pharmacology

2011

13

Page 1